natgillin/translations-raw huggingface dataset:
Nasal spray, suspension 1 bottle - 30 sprays 1 bottle - 60 sprays 1 bottle - 120 sprays 
pršilo za nos, suspenzija 1 steklenica - 30 vpihov 1 steklenica - 60 vpihov 1 steklenica - 120 vpihov
Glaxo Operations UK Ltd (trading as Glaxo Wellcome Operations) Harmire Road 
Glaxo Operations UK Ltd (pod imenom Glaxo Wellcome Operations) Harmire Road
• If symptoms are very bad your doctor may increase the dose to 2 sprays in each nostril once every day until the symptoms are under control. 
• Če so simptomi zelo hudi, lahko zdravnik odmerek poveča na 2 vpiha v vsako nosnico enkrat na dan, dokler simptomi niso pod nadzorom.
Other medicines and Avamys 
Druga zdravila in zdravilo Avamys
Detailed information on this medicine is available on the European Medicines Agency website: http://www.ema.europa.eu 
Podrobne informacije o tem zdravilu so objavljene na spletni strani Evropske agencije za zdravila: http://www.ema.europa.eu.
7 If your dose is 2 sprays in each nostril repeat steps 4 to 6. 
7 Če je vaš odmerek 2 vpiha v vsako nosnico, ponovite korake od 4 do 6. 8 Ponovite korake od 4 do 7 za zdravljenje na drugi nosnici.
• medicines for asthma 
• zdravila za zdravljenje astme,
Your doctor will assess whether you should take Avamys with these medicines. 
Zdravnik bo presodil, če smete zdravilo Avamys uporabljati skupaj s temi zdravili.
Children under 6 years of age 
Otroci, mlajši od 6 let
Less than 1 % of dose-related material is excreted in urine and therefore renal impairment would not be expected to affect the pharmacokinetics of fluticasone furoate. 
Z urinom se izloči manj kot 1 % vnesenega odmerka, zato v primeru okvare ledvic vpliva na farmakokinetiko flutikazonfuroata ne pričakujemo.
The nasal spray is now ready for use. 
Pršilo za nos je sedaj pripravljeno za uporabo.
Onset of therapeutic benefit was observed as early as 8 hours after initial administration, with further improvement observed for several days afterwards. 
Pojav terapevtske koristi so opazili že 8 ur po začetku uporabe, po nekaj dneh zdravljenja pa so poročali še o nadaljnjem izboljšanju.
Avamys is indicated in adults, adolescents and children (6 years and over) 
Zdravilo Avamys je indicirano pri odraslih, mladostnikih in otrocih (starih 6 let ali več).
Fluticasone furoate should be used in pregnancy only if the benefits to the mother outweigh the potential risks to the foetus or child. 
Flutikazonfuroat se sme med nosečnostjo uporabljati le, če koristi za mater prevladajo nad kakršnimkoli tveganjem za plod ali otroka.
Therefore, children should be maintained on the lowest possible efficacious dose which delivers adequate symptom control (see section 4.2). 
Zato je treba za vzdrževalno zdravljenje otrok uporabljati najmanjši možni učinkoviti odmerek, ki zagotovi ustrezno obvladovanje simptomov (glejte poglavje 4.2).
Fluticasone furoate is a synthetic trifluorinated corticosteroid that possesses a very high affinity for the glucocorticoid receptor and has a potent anti-inflammatory action. 
Flutikazonfuroat je sintetični trifluorirani kortikosteroid z zelo veliko afiniteto za glukokortikoidne receptorje in močnim protivnetnim delovanjem.
Coadministration should be avoided unless the benefit outweighs the increased risk of systemic corticosteroid side effects, in which case patients should be monitored for systemic corticosteroid side effects. 
Sočasni uporabi se je treba izogniti, razen če korist odtehta povečano tveganje za pojav sistemskih neželenih učinkov kortikosteroidov; v tem primeru je treba bolnike nadzorovati glede sistemskih neželenih učinkov kortikosteroidov.
1 Wipe the nozzle and inside of the cap with a clean, dry tissue - see pictures i and j. 
1 Obrišite nastavek in notranjost pokrovčka s čisto, suho krpico - glejte sliki i in j.
There was no evidence for a higher incidence of patients with quantifiable fluticasone furoate concentrations in the elderly, when compared with the younger patients. 
Ni dokazov o večji pojavnosti merljivih koncentracij flutikazonfuroata pri starejših bolnikih v primerjavi z mlajšimi bolniki.
Adults and adolescents (12 years and over) 
Odrasli in mladostniki (stari 12 let in starejši)
Your doctor may wish to monitor you carefully if you are taking any of these medicines as they may increase the side effects of Avamys. 
Če jemljete katero od teh zdravil, vas bo zdravnik morda skrbno spremljal, kajti ta zdravila lahko povečajo neželene učinke zdravila Avamys.
• Nasal ulceration - which may cause irritation or discomfort in your nose. 
• razjeda v nosu - ki lahko povzroči draženje in neprijeten občutek v nosu.
• may cause eye conditions such as glaucoma (increase in pressure in the eye) or cataracts (clouding of the lens of the eye). 
• lahko povzroči spremembe na očeh, npr. glavkom (zvišan očesni tlak) ali katarakto (zamotnitev očesne leče).
Look at the level through the window. 
Raven preverite skozi okence.
Findings in general toxicology studies were similar to those observed with other glucocorticoids and are associated with exaggerated pharmacological activity. 
Ugotovitve študij splošne toksičnosti so podobne ugotovitvam pri študijah z drugimi glukokortikoidi in se nanašajo na poudarjeno farmakološko delovanje.
In a bioavailability study, intranasal doses of up to 2640 micrograms per day were administered over three days with no adverse systemic reactions observed (see section 5.2). 
V študiji biološke uporabnosti so tri dni uporabljali nazalne odmerke do 2.640 mikrogramov na dan, pri čemer neželenih sistemskih reakcij niso opazili (glejte poglavje 5.2).
The nasal spray comes in an amber glass bottle inside a plastic casing - see picture a. It will contain either 30, 60 or 120 sprays, depending on the pack size that has been prescribed for you. 
Pršilo za nos je na voljo v steklenički jantarne barve v plastičnem ohišju - glejte sliko a. Vsebuje količino zdravila za 30, 60 ali 120 vpihov, odvisno od velikosti pakiranja, ki vam ga je predpisal zdravnik.
Avamys is available in pack sizes 30, 60 and 120 sprays. 
Zdravilo Avamys je na voljo v pakiranjih za 30, 60 in 120 vpihov.
If there is any reason to believe that adrenal function is impaired, care must be taken when transferring patients from systemic steroid treatment to fluticasone furoate. 
Če obstaja kakšen razlog za domnevo o okvarjenem delovanju nadledvičnih žlez, je pri prehodu bolnikov s sistemskega steroidnega zdravljenja na flutikazonfuroat potrebna previdnost.
4 Place the nozzle in one of your nostrils - see picture g. Point the end of the nozzle slightly outwards, away from the centre ridge of your nose. 
Dajte nastavek v eno od nosnic - glejte sliko g. Usmerite konec nastavka rahlo navzven, proč od nosnega pretina.
If you need to check how much is left hold the nasal spray upright against a bright light. 
Če želite preveriti, koliko zdravila je še ostalo, držite pršilo za nos obrnjeno pokonci proti močni svetlobi.
The casing has a window for viewing the bottle contents. 
Na ohišju je okence, ki omogoča vpogled v vsebino stekleničke.
Children (6 to 11 years of age) 
Otroci (stari od 6 do 11 let)
In children this side effect can cause them to grow more slowly than others. 
Pri otrocih lahko ta neželeni učinek povzroči počasnejšo rast.
• If it is still not working, or if it produces a jet of liquid, take the nasal spray back to the pharmacy to get advice. 
• Če še vedno ne deluje ali če brizgne tekočino, nesite pršilo v lekarno, kjer vam bodo svetovali.
Fluticasone furoate is rapidly cleared (total plasma clearance of 58.7 l/h) from systemic circulation principally by hepatic metabolism to an inactive 17β-carboxylic metabolite (GW694301X), by the cytochrome P450 enzyme CYP3A4. 
Flutikazonfuroat se hitro očisti iz sistemske cirkulacije (skupni plazemski očistek 58,7 l/h), predvsem s presnovo v jetrih do neaktivnega 17-karboksilnega presnovka (GW694301X) z encimom CYP3A4 citokroma P450.
If the nasal spray does not seem to be working: 
Če pršilo za nos noče delovati:
Paediatric exposure to fluticasone furoate in safety and efficacy studies in seasonal and perennial allergic rhinitis included 243 patients 12 to <18 years, 790 patients 6 to <12 years and 241 patients 2 to <6 years. 
Izpostavljenost pediatričnih bolnikov flutikazonfuroatu v študijah varnosti in učinkovitosti pri sezonskem in celoletnem alergijskem rinitisu je vključevala 243 bolnikov, starih od 12 do < 18 let, 790 bolnikov, starih od 6 do < 12 let, in 241 bolnikov, starih od 2 do < 6 let.
What Avamys is and what it is used for What you need to know before you use Avamys How to use Avamys 
Kaj je zdravilo Avamys in za kaj ga uporabljamo Kaj morate vedeti, preden boste uporabili zdravilo Avamys Kako uporabljati zdravilo Avamys Možni neželeni učinki
Fertility There are no fertility data in humans. 
Plodnost Podatkov o plodnosti pri človeku ni.
The medicinal product is available in three pack sizes: 1 bottle of 30, 60 or 120 sprays. 
Zdravilo je na voljo v treh pakiranjih: 1 steklenička s 30, 60 ali 120 vpihi.
There are no adequate data from the use of fluticasone furoate in pregnant women. 
Podatki o uporabi flutikazonfuroata med nosečnostjo niso zadostni.
What you need to know before you use Avamys 
Kaj morate vedeti, preden boste uporabili zdravilo Avamys
Nasal corticosteroids can affect the normal production of hormones in your body, particularly if you use high doses for a long time. 
Nazalni kortikosteroidi lahko vplivajo na normalno nastajanje hormonov v vašem telesu, predvsem ob dolgotrajnem jemanju visokih odmerkov.
Potential systemic effects may include Cushing's syndrome, Cushingoid features, adrenal suppression, growth retardation in children and adolescents, cataract, glaucoma and more rarely, a range of psychological or behavioural effects including psychomotor hyperactivity, sleep disorders, anxiety, depression or aggression (particularly in children). 
Med možnimi sistemskimi učinki so lahko Cushingov sindrom, Cushingoidne značilnosti, zavora delovanja nadledvičnih žlez, upočasnitev rasti pri otrocih in mladostnikih, katarakta, glavkom in, redkeje, vrsta psiholoških ali vedenjskih učinkov, med njimi psihomotorična hiperaktivnost, motnje spanja, anksioznost, depresija ali napadalnost (zlasti pri otrocih).
• When you first use the nasal spray you will need to shake it vigorously with the cap on for about 10 seconds. 
• Ko uporabite pršilo za nos prvič, ga morate (z nameščenim pokrovčkom) približno 10 sekund močno stresati.
In animal studies glucocorticoids have been shown to induce malformations including cleft palate and intra-uterine growth retardation. 
Študije na živalih so pokazale, da glukokortikoidi povzročajo malformacije, vključno z razcepljenim nebom, in zaostajanje razvoja v maternici.
• The mist-release button must be pressed firmly all the way in, to release the mist through the nozzle - see picture c. 
• Gumb za sprostitev meglice morate pritisniti močno povsem do konca noter, da se skozi nastavek sprosti meglica - glejte sliko c.
Avamys is indicated for the treatment of the symptoms of allergic rhinitis. 
Zdravilo Avamys je indicirano za zdravljenje simptomov alergijskega rinitisa.
Avamys contains benzalkonium chloride 
Zdravilo Avamys vsebuje benzalkonijev klorid.
The safety in children under 6 years has not been well established. 
Varnost pri otrocih, mlajših od 6 let, še ni bila dokazana.
In some patients benzalkonium chloride can cause irritation in the inside of the nose. 
Benzalkonijev klorid lahko pri nekaterih bolnikih povzroči draženje nosne sluznice.
These events were transient in nature for six subjects in the fluticasone furoate group and one placebo subject. 
Ti dogodki so bili prehodni pri šestih preiskovancih v skupini s flutikazonfuroatom in pri enem preiskovancu v skupini s placebom.
5 Press the button firmly all the way in, while you breathe in through your nose - see picture h. 
Močno pritisnite gumb povsem do konca, medtem ko vdihnete skozi nos - glejte sliko h.
Only a small number of elderly patients (≥ 65 years, n=23/872; 2.6 %) provided pharmacokinetic data. 
Farmakokinetični podatki so bili pridobljeni le pri manjšem številu starejših bolnikov ( 65 let, n = 23/872; 2,6 %).
Acute overdose is unlikely to require any therapy other than observation. 
Verjetnost, da bi bilo v primeru akutnega prevelikega odmerjanja potrebno kakršnokoli zdravljenje, razen opazovanja, je majhna.
Epistaxis *In paediatric clinical studies of up to 12 weeks duration the incidence of epistaxis was similar between patients receiving fluticasone furoate and patients receiving placebo. 
Krvavitev iz nosu *V kliničnih študijah pri otrocih, ki so trajale do 12 tednov, je bila pojavnost krvavitev iz nosu podobna pri bolnikih, ki so prejemali flutikazonfuroat, in bolnikih, ki so prejemali placebo.
If you use more Avamys than you should Talk to your doctor or pharmacist. 
Če ste uporabili večji odmerek zdravila Avamys, kot bi smeli Posvetujte se s svojim zdravnikom ali farmacevtom.
The absolute bioavailability for intranasal fluticasone furoate is 0.50 %, such that less than 1 microgram of fluticasone furoate would be systemically available after administration of 110 micrograms (see section 4.9). 
Absolutna biološka uporabnost nazalnega flutikazonfuroata je 0,50-odstotna, tako, da je pri uporabi 110 mikrogramskega odmerka sistemsko razpoložljivega manj kot 1 mikrogram flutikazonfuroata (glejte poglavje 4.9).
Fluticasone furoate nasal spray significantly improved the patients' perception of overall response to therapy, and the patients' disease-related quality of life (Rhinoconjunctivitis Quality of Life Questionnaire - RQLQ), in all 4 studies. 
Flutikazonfuroat v obliki pršila za nos je v vseh 4 študijah pomembno izboljšal bolnikov vtis o celotnem odzivu na zdravljenje in z boleznijo povezano kakovost življenja bolnika (vprašalnik o kakovosti življenja z rinokonjunktivitisom; “Rhinoconjunctivitis Quality of Life Questionnaire”RQLQ).
Symptoms include: - becoming very wheezy, coughing or having difficulty with breathing - suddenly feeling weak or light-headed (which may lead to collapse or loss of consciousness) - swelling around the face - skin rashes or redness. 
Med simptomi so: - zelo piskajoče dihanje, kašelj ali težko dihanje, - nenaden občutek slabosti ali vrtoglavosti (to lahko povzroči kolaps ali izgubo zavesti), - oteklost obraza, - izpuščaj ali pordelost kože.
Based on data with another glucocorticoid (fluticasone propionate), that is metabolised by CYP3A4, coadministration with ritonavir is not recommended because of the risk of increased systemic exposure of fluticasone furoate. 
Na osnovi podatkov, pridobljenih z drugim kortikosteroidom (flutikazonpropionatom), ki se presnavlja s CYP3A4, sočasne uporabe ritonavirja ne priporočamo zaradi tveganja za večjo sistemsko izpostavljenost flutikazonfuroatu.
There was no effect on serum cortisol in subjects with severe hepatic impairment (fluticasone furoate/vilanterol 100/12.5 micrograms). 
Pri preiskovancih s hudo okvaro jeter ni bilo vpliva na kortizol v serumu (flutikazonfuroat/vilanterol 100/12,5 mikrograma).
These findings are not likely to be relevant for humans given recommended nasal doses which results in minimal systemic exposure. 
Malo je verjetno, da bi bile te ugotovitve pomembne za uporabo priporočenih nazalnih odmerkov pri človeku, pri katerih je dosežena minimalna sistemska izpostavljenost.
Systemic effects of nasal corticosteroids may occur, particularly when prescribed at high doses for prolonged periods (see section 4.4). 
Pojavijo se lahko sistemski učinki nazalnih kortikosteroidov, še posebej pri uporabi visokih odmerkov daljši čas (glejte poglavje 4.4).
Seasonal and perennial allergic rhinitis in children (under 6 years): 
Sezonski in celoletni alergijski rinitis pri otrocih (mlajših od 6 let):
Mean growth velocity over the 52-week treatment period was lower in the patients receiving fluticasone furoate (5.19 cm/year) compared to placebo (5.46 cm/year). 
Povprečna hitrost rasti je bila v 52-tedenskem obdobju manjša med prejemniki flutikazonfuroata (5,19 cm/leto) kot med prejemniki placeba (5,46 cm/leto).
Musculoskeletal and connective tissue disorders (Children) Not known 
Bolezni mišično-skeletnega sistema in vezivnega tkiva (otroci)
The paediatric posology is based on assessment of the efficacy data across the allergic rhinitis population in children. 
Odmerjanje pri otrocih temelji na oceni podatkov o učinkovitosti pri skupini otrok z alergijskim rinitisom.
In a two-year study designed to assess the ocular safety of fluticasone furoate (110 micrograms once daily intranasal spray), adults and adolescents with perennial allergic rhinitis received either fluticasone furoate (n=367) or placebo (n=181). 
V dveletni študiji za oceno očesne varnosti flutikazonfuroata (110 mikrogramov enkrat na dan v pršilu za nos) so odrasli in mladostniki s celoletnim alergijskim rinitisom prejemali flutikazonfuroat (n = 367) ali placebo (n = 181).
A randomised, double-blind, parallel-group, multicenter, one-year placebo-controlled clinical growth study evaluated the effect of fluticasone furoate nasal spray 110 micrograms daily on growth velocity in 474 prepubescent children (5 to 7.5 years of age for girls and 5 to 8.5 years of age for boys) with stadiometry. 
V randomizirani, dvojno slepi, multicentrični, enoletni, s placebom kontrolirani klinični študiji rasti z vzporednima skupinama so s stadiometrijo ocenili učinek 110 mikrogramov flutikazonfuroata na dan v nosnem pršilu na hitrost rasti pri 474 otrocih pred puberteto (deklice v starosti od 5 do 7,5 let in dečki v starosti od 5 do 8,5 let).
Allergy symptoms can occur at specific times of the year and be caused by allergy to pollen from grass or trees (hayfever), or they can occur all year round and be caused by allergy to animals, house-dust mites or moulds to name some of the most common. 
Simptomi alergije se lahko pojavijo v določenem letnem času kot posledica preobčutljivosti za cvetni prah trav ali dreves (seneni nahod), ali pa se pojavljajo skozi vse leto kot posledica preobčutljivosti za živali, hišne pršice ali plesni, če omenimo nekatere najpogostejše.
Efficacy was maintained over the full 24-hours dosing period with once daily administration. 
Pri odmerjanju enkrat na dan se je učinkovitost ohranila celotno 24-urno odmerno obdobje.
The principal route of metabolism was hydrolysis of the Sfluoromethyl carbothioate function to form the 17β-carboxylic acid metabolite. 
Glavna pot presnove je hidroliza S-fluorometil karbotioata do presnovka 17karboksilne kisline.
If there is evidence for higher than recommended doses being used, then additional systemic corticosteroid cover should be considered during periods of stress or elective surgery. 
V primeru dokaza, da je bolnik uporabljal odmerke, višje od priporočenih, je treba v obdobju stresa ali načrtovanega kirurškega posega razmisliti o dodatni uporabi sistemskih kortikosteroidov.
The cap keeps the dust out, seals in the pressure and stops the nozzle from blocking up. 
Pokrovček ščiti pred prahom, ohranja tlak in preprečuje zamašitev nastavka.
If growth is slowed, therapy should be reviewed with the aim of reducing the dose of nasal corticosteroid if possible, to the lowest dose at which effective control of symptoms is maintained. 
Če se rast upočasni, je treba zdravljenje ponovno ovrednotiti in odmerek nazalnega kortikosteroida po možnosti zmanjšati na najmanjši odmerek, ki še zagotavlja učinkovito nadzorovanost simptomov.
Growth retardation **In a one-year clinical study assessing growth in pre-pubescent children receiving 110 micrograms of fluticasone furoate once daily, an average treatment difference of -0.27 cm per year in growth velocity was observed compared to placebo (see Clinical efficacy and safety). 
Upočasnitev rasti **V enoletni klinični študiji, ki je ocenjevala rast otrok pred puberteto, zdravljenih s 110 mikrogrami flutikazonfuroata enkrat na dan, so pri teh otrocih ugotovili povprečno razliko v hitrosti rasti -0,27 cm na leto v primerjavi s prejemniki placeba (glejte Klinična učinkovitost in varnost).
When the cap is in place the mistrelease button cannot be pressed accidentally. 
Če je pokrovček nameščen, ni mogoče pomotoma pritisniti gumba za sprostitev meglice.
3 years In-use shelf life: 2 months 
3 leta Rok uporabnosti po prvem odprtju: 2 meseca.
• ketoconazole, used to treat fungal infections 
• ketokonazol, ki ga uporabljamo pri zdravljenju glivičnih bolezni.
The enzyme induction and inhibition data suggest that there is no theoretical basis for anticipating metabolic interactions between fluticasone furoate and the cytochrome P450 mediated metabolism of other compounds at clinically relevant intranasal doses. 
Podatki o encimski indukciji in inhibiciji kažejo, da teoretična osnova za pričakovane presnovne reakcije med flutikazonfuroatom in drugimi učinkovinami, ki se presnavljajo s citokromom P450, pri klinično pomembnih nazalnih odmerkih ne obstaja.
• Use once a day 
• Zdravilo uporabljajte enkrat na dan.
If you have any further questions on the use of this medicine, or if you have any discomfort using the nasal spray ask your doctor or pharmacist or nurse. 
Če imate dodatna vprašanja o uporabi tega zdravila ali če vam uporaba pršila za nos povzroča kakšno nelagodje, se posvetujte z zdravnikom, farmacevtom ali medicinsko sestro.
What Avamys looks like and contents of the pack 
Izgled zdravila Avamys in vsebina pakiranja
At weeks 52 and 104, the majority of subjects (>95%) had IOP values of within ± 5mmHg of the baseline value. 
Po 52 in 104 tednih je imela večina preiskovancev (> 95 %) očesni tlak znotraj ± 5 mm Hg v primerjavi z izhodiščem.
• may when taken for a long time cause children to grow more slowly. 
• lahko pri dolgotrajni uporabi upočasni rast pri otrocih.
There were over 2700 patients treated with fluticasone furoate in safety and efficacy studies for seasonal and perennial allergic rhinitis. 
V študijah varnosti in učinkovitosti je bilo več kot 2700 bolnikov zdravljenih s flutikazonfuroatom zaradi sezonskega in celoletnega alergijskega rinitisa.
Fluticasone furoate undergoes incomplete absorption and extensive first-pass metabolism in the liver and gut resulting in negligible systemic exposure. 
Absorpcija flutikazonfuroata je nepopolna, presnova prvega prehoda v jetrih in črevesu pa obsežna, zato je sistemska izpostavljenost malenkostna.
Data are available following inhaled administration of fluticasone furoate (as fluticasone furoate or fluticasone furoate/vilanterol) to subjects with hepatic impairment that are also applicable for intranasal dosing. 
Na voljo so podatki po inhalacijski uporabi flutikazonfuroata (v obliki flutikazonforuata ali kombinacije flutikazonfuroat/vilanterol) pri preiskovancih z okvaro jeter; ti podatki veljajo tudi za intranazalno uporabo.
A 6-week study that assessed the effect of fluticasone furoate nasal spray 110 micrograms once daily on adrenal function in children aged 2 to 11 years showed that there was no significant effect on 24-hour serum cortisol profiles, compared with placebo. 
6-tedenska študija, ki je vrednotila učinek flutikazonfuroata v obliki pršila za nos v odmerku 110 mikrogramov enkrat na dan na delovanje nadledvičnih žlez pri otrocih, starih od 2 do 11 let, je pokazala, da v primerjavi s placebom ne prihaja do pomembnejšega učinka na vrednosti 24-urnega kortizola v serumu.
In a drug interaction study of intranasal fluticasone furoate with the potent CYP3A4 inhibitor ketoconazole there were more subjects with measurable fluticasone furoate concentrations in the ketoconazole group (6 of the 20 subjects) compared to placebo (1 out of 20 subjects). 
V študiji medsebojnega delovanja med nazalnim flutikazonfuroatom in ketokonazolom, močnim zaviralcem CYP3A4, so o večjem številu oseb z merljivimi koncentracijami flutikazonfuroata poročali v skupini, ki je prejemala ketokonazol (6 od 20 oseb), kot v skupini, ki je prejemala placebo (1 od 20 oseb).
• If you think the nozzle may be blocked, don't use a pin or anything sharp to clear it. 
• Če mislite, da je nastavek zamašen, za njegovo čiščenje ne uporabite igle ali česa drugega ostrega.